Albuminuria and ACEI/ARB among HIV-patients
Career Development Fellow: Dr Mosepele Mosepele
Albuminuria among virally-suppressed HIV-infected patients in Botswana: longitudinal changes and association with inflammation and ACEI/ARB use in a clinical setting

University of Cape Town (UCT), Cape Town, South Africa
Starting date: 1 July 2019
Duration: 36 months
Grant amount: EUR 148,403
Grant agreement: TMA2017CDF-1928

Bethink TB
Career Development Fellow: Dr Virginie Rozot
NK and B cell determinants of immunity to Mycobacterium tuberculosis in humans

University of Cape Town (UCT), Cape Town, South Africa 
Starting date: 1 January 2019
Duration: 36 months
Grant amount: EUR 149,990
Grant agreement: TMA2017CDF-1905

CaNPSTS</strong >
Career Development Fellow: Dr Charles Drago Kato
Clinical evaluation of novel plasma biomarkers for stage diagnosis among sleeping sickness patients in Uganda

Makerere University, Kampala, Uganda
Starting date: 1 January 2019
Duration: 36 months
Grant amount: EUR 130,125
Grant agreement: TMA2017CDF-1887

ERAIN
Career Development Fellow: Dr Moses Masika
Emerging and re-emerging arboviral infections in Nairobi, Kenya

University of Nairobi, Nairobi, Kenya 
Starting date: 1 July 2019
Duration: 36 months
Grant amount: EUR 149,488
Grant agreement: TMA2017CDF-1865

FAST
Career Development Fellow: Dr Grace McHugh
Feasibility and acceptability of HIV self-testing in adolescents and young people

Biomedical Research and Training Institute (BRTI), Harare, Zimbabwe
Starting date: 1 October 2018
Duration: 28 months
Grant amount: EUR 141,745
Grant agreement: TMA2017CDF-1923

HighRif-C
Career Development Fellow: Hadija Semvua
Evaluation of pharmacokinetics and safety/tolerability of higher doses of rifampicin in children with newly diagnosed, uncomplicated tuberculosis

The Good Samaritan Foundation, Kilimanjaro Christian Medical Centre, Moshi, Tanzania 
Starting date: 1 July 2019
Duration: 36 months
Grant amount: EUR 149,621
Grant agreement: TMA2017CDF-1876

HypnoBio
Career Development Fellow: Dr Laurent Dembélé
Understanding the biology of Plasmodium vivax and Plasmodium ovale for the development of a field-based anti-hypnozoite drug screening model

Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali
Starting date: 1 December 2018
Duration: 36 months
Grant amount: EUR 148,000
Grant agreement: TMA2017CDF-1892

ID93-TBVaccine
Career Development Fellow: Dr Babatunde A. Adeagbo
Strategies to optimise the stability and bio-activity of a clinical tuberculosis vaccine

Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
Starting date: 1 October 2018
Duration: 46 months
Grant amount: EUR 149,999
Grant agreement: TMA2017CDF-1860

Informa-TB
Career Development Fellow: Dr Marisa Klopper
The role of Mycobacterium tuberculosis compensatory mutations in metabolic fitness via the structure and function of mycolic acids

Stellenbosch University, Stellenbosch, South Africa
Starting date: 1 December 2018
Duration: 36 months
Grant amount: EUR 150,000
Grant agreement: TMA2017CDF-1885

Latent HIV-1, Viral Suppress and Hope for HIV Cure
Career Development Fellow: Dr Edward Maina
Investigation of the impact of inducible, replication-competent latent HIV-1 as an impediment to HIV/AIDS cure in the context of sustained viral suppression

Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
Starting date: 1 May 2019
Duration: 36 months
Grant amount: EUR 149,500
Grant agreement: TMA2017CDF-1852

Mal-Brain Study
Career Development Fellow: Dr Symon Kariuki
Impact of RTS,S/AS01 vaccine and insecticide- treated bed nets on neurobehavioural impairment and school participation in children from rural Kenya

African Research Collaboration for Health Ltd, Kilifi, Kenya
Starting date: 1 March 2019
Duration: 36 months
Grant amount: EUR 149,623
Grant agreement: TMA2017CDF-1903

MOSAIC Career Development Fellow: Dr Charissa C. Naidoo
The longitudinal microbiome of South African tuberculosis patients, symptomatic culture-negative controls and healthy household contacts, and its association with treatment outcome

Stellenbosch University, Stellenbosch, South Africa
Starting date: 1 March 2019
Duration: 36 months
Grant amount: EUR 149,996
Grant agreement: TMA2017CDF-1914

Preg_multidrug
Career Development Fellow: Dr Tacilta Nhampossa
Understanding the determinants of the effectiveness of HIV control strategies targeting HIV-infected pregnant women in Mozambique

Fundação Manhiça, Maputo, Mozambique
Starting date: 1 February 2019
Duration: 36 months
Grant amount: EUR 149,098
Grant agreement: TMA2017CDF-1927

PENETRATE
Career Development Fellow: Dr C.G. Banda
Impact of standard antiretroviral therapy on the pharmacokinetic profile and placental penetration of piperaquine administered as dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria among HIV-infected pregnant women in Malawi

University of Malawi, Blantyre, Malawi 
Starting date: 1 September 2018
Duration: 36 months
Grant amount: EUR 149,999
Grant agreement: TMA2017CDF-1897

PERHAPS
Career Development Fellow: Dr Gbolahan Ajibola
Effects of preterm birth on HIV acquisition risk and antiretroviral prophylaxis safety in HIV-exposed infants in Botswana

Botswana-Harvard AIDS Institute Partnership (BHP), Gaborone, Botswana 
Starting date: 1 November 2018
Duration: 18 months
Grant amount: EUR 75,431
Grant agreement: TMA2017CDF-1906

PRIMAQUINE Roll-out
Career Development Fellow: Dr Dominic Mosha
Monitoring safety of single low-dose primaquine co-administered with AL in routine healthcare practices: addressing potential implementation challenges and policy options for effective roll-out

Ifakara Health Institute (IHI), Dar es Salaam, Tanzania 
Starting date: 1 January 2019
Duration: 30 months
Grant amount: EUR 149,720
Grant agreement: TMA2017CDF-1878